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Summary: Mouse models have been generated to assess the roles of 
selenoproteins involved with housekeeping tasks and/or stress-related pheno- 
mena in development and health. Each mouse model has taken advantage of 
the fact that the synthesis of all seleno roteins is dependent on the expression z of two selenocysteine (Sec) ~RNA['=~] i so fom that differ fiom each other 
by a single methyl group on the ribosyl moiety at position 34. The 
endogenous Sec population was selectively altered by generating 
mouse models involving 1) transgenic animals carrying mutant or wild type 
S ec ~ R N A [ ~ ~ ~ ~ ~  transgenes, 2) conditional knockout animals carrying a 
floxed Sec ~RNA'" ']~~~ gene that was targeted for removal in specific tissues 
and organs using loxP-Cre technology and 3) transgeniclstandard knockout 
animals carrying mutant or wild type transgenes and a knockout of the Sec 
~RNA[-]&~ gene wherein the animal's survival is dependent on the 
transgene. These mouse models perturbed selenoprotein expression, often in 
a protein- and tissue-specific manner, permitting us to better assess their 
function in health and development. 
'RI is also affiliated with the Molecular Biology of Selenium Section, Laboratory of Cancer 
Prevention, CCR, NCI, NIH, Bethesda, MD 20892. 
Selenium: Its molecular biology and role in human health 
Introduction 
Numerous human clinical trials examining the role of selenium in health 
have been initiated recently, or have already been completed. Perhaps the 
most famous of those studies that have been completed is that of Clark et a1 
[I]. These investigators reported in 1996 that supplementing the diet with 
200 micrograms of seleniumlday reduced the incidence of prostate and colon 
cancers by more than 50% and lung cancer by about 35%. This study 
provided the basis for numerous subsequent human clinical trials involving 
selenium. For example, the largest human clinical t ial  ever undertaken, the 
Selenium and Vitamin E Cancer Prevention Trial (SELECT [2]), involves 
more than 35,000 males in determining whether selenium and vitamin E may 
play a role in protecting men against prostate cancer. Another human clinical 
trial recently undertaken involves 1960 individuals in determining whether 
selenium may have a role in preventing the occurrence of secondary lung 
tumors in patients with a previous surgically removed non-small cell lung 
lesion [3]. These trials are being carried out at the cost of hundreds of 
millions of dollars with little or no understanding of how selenium acts 
metabolically to bring about potential health benefits. It is important 
therefore to generate mouse models to determine how selenium acts at the 
molecular level in promoting better health and to determine whether small 
molecular weight selenocompounds andlor selenoproteins are the responsible 
agents. 
Selenoproteins are dependent on Sec ~RNA['"]~' for their expression as 
discussed in detail in Chapter 3 (see also [4,5]). In addition, the Sec 
~ R N A [ ~ ~ ~ ~ ~ ~ ~  population in mammalian cells is composed of two major 
isoforms that differ from each other by a 2'-0-methylribosyl moiety at 
position 34 which is designated Urn34 (Chapter 3 and [4,5]). The two 
isoforms, designated mcmSu and mcm5um, have different roles in 
selenoprotein synthesis wherein mcmSu appears to be largely responsible for 
the expression of housekeeping selenoproteins and mcmSum largely 
responsible for selenoproteins involved in stress-related phenomena [6,7]. 
By perturbing the expression of Sec t w S " I S e c  in mice, selenoprotein 
synthesis can be altered in such a way that their roles in development and 
health can be readily studied. In fact, Sec ~ R N A I ~ ~ ~ ~ ~ ~ ~  synthesis can be 
modulated in various ways in generating different mouse lines so that the 
roles of selenoproteins involved in housekeeping tasks and in stress-related 
phenomena can be elucidated. We have generated several mouse models for 
examining the role of selenoproteins in development and health. These 
mouse models involve generating transgenic, standard knockout, conditional 
knockout or a combination of transgenic/knockout mice encoding either wild 
type or a mutant Sec ~RNA[~~]" '  gene or transgene. It should also be noted 
that the characteristics and properties of a number of individual 
selenoproteins have been examined, including being targeted for removal, to 
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assess their roles in health and development (see the Chapters in Part 11. 
Selenium-containing proteins). 
Mouse models for elucidating the role of selenoproteins in development 
and health 
To generate mouse models for elucidating selenoprotein function, we took 
advantage of the fact that selenoprotein synthesis is dependent on the 
presence of Sec ~ R N A [ ~ ~ ~ ~ ~ ~ .  Our mouse models involve the introduction of a 
transgene, designated trspt, or manipulation of the Sec ~ R N A [ ~ ~ ] & ~  gene, 
designated trsp and they are summarized as follows: 1) transgenic mice 
carrying wild type or a mutant trspt [a]; 2) conditional knockout mice 
carrying a floxed trsp that can be specifically targeted for removal using 
loxP-Cre technology [9]; and 3) standard knockout/transgenic mice 
containing trsp knockout, designated Atrsp, and carrying wild type or mutant 
trsp transgenes in which the survival of the animal is dependent on the 
transgene [6,7]. A fourth mouse model is also briefly discussed wherein 
transgenic/conditional knockout mice carrying two transgenes, a Cre 
transgene under control of a promoter targeted for a specific organ or tissue, 
and a wild type or mutant trspt in addition to the targeted (floxed) trsp (B.A. 
Carlson, M.E. Moustafa, R. Shrimali, M. Rao, N. Zhong, S. Wang, L. 
Feigenbaum, B.J. Lee, V.N. Gladyshev and D.L. Hatfield, submitted). The 
mouse models are shown in Table 1. They were prepared for assessing the 
roles of selenoproteins in health and development as well as defining the 
roles of the two Sec ~ R N A ~ ~ ~ ~ ~ ~ ~  isoforms, mcmSu and mcm5um, in 
selenoprotein synthesis. Since the role of mcm5u, which is largely involved 
in the expression of housekeeping selenoproteins, and of mcmSLJm, which is 
largely involved in the expression of selenoproteins involved in stress-related 
phenomena, has been discussed in Chapter 3 and detailed elsewhere [5-71, 
the emphasis of the present chapter is on generating mouse models for 
examining the roles of selenoproteins in health and development. It should 
be noted that some of our mouse models may also be used to elucidate the 
role of small molecular weight selenocompounds in disease prevention. 
Transgenic mouse models 
Transgenic mice are generated by introducing one or more copies of the wild 
type or mutant trsp into the mouse genome. The resulting mice are then bred 
to obtain a stable breeding population (i.e., mice that are homozygous for the 
transgene). Mutations were made at either position 37 [8] or at postion 34 in 
Sec ~ R N A I ~ ~ ~ ~ ~ ~  for preparing mutant transgenes. The base at position 37 in 
the fully maturated ~ R N A [ ~ ~ ~ ~  is isopentenyladenosine (i6A), while that at 
position 34 is mcmSu (see Chapter 3 or [4,5]). The base at position 37 was 
changed to G (A37->G37) and that at position 34 to A (T34->A34). 
Importantly, neither of these two, very different, mutant tRNAs contain 
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Um34, the methyl group located at the 2'-hydroxylribose on mcmSu [lo]. 
An A in the wobble position of the anticodon in any tRNA is normally 
converted to I. About 65% of the A34 mutant Sec ~RNA[&']~" is converted to 
I34 in mouse liver (B.A. Carlson, M.E. Moustafa, R. Shrimali, M. Rao, N. 
Zhong, S. Wang, L. Feigenbaum, B.J. Lee, V.N. Gladyshev and D.L. 
Hatfield, submitted)$ and interestingly, the ACA and ICA anticodons in A34 
Sec ~ R N A [ ~ ' ~ " ~  decode UGU and UGU, UGC (UGU and UGC are codons 
for cysteine) and UGA (UGA is the codon for Sec), respectively. 
Table 1. Mouse models and their uses. 
"Genotype designations used for mouse models (see text). 
%ses - the various uses of the mouse models with accompanying references (see also text). 
"SP - selenoprotein(s). 
d~~ - knockout. 
"AM Diamond, personal communication. 
/R Irons, BA Carlson, DL Hatfield, C Davis, submitted. 
Carlson, ME Moustafa, R Shrimali, M Rao, N Zhong, S Wang, L Feigenbaum, BJ Lee, 
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Mouse models in health and development 
Initially, the resulting transgenic mice encoding multiple copies of trspt and 
G37trspt (see Table 1) were examined [8]. This study provided the first 
example of transgenic mice engineered to contain functional tRNA 
transgenes. The fact that over-expression of wild type Sec due to 
the extra copies of trspt did not appear to influence selenoprotein synthesis in 
the or ans and tissues examined suggested that the levels of the Sec 
tRNA['rlb isoforms were not limiting in protein synthesis (reviewed in 
[4,5]). However, mice carrying G37trspt had a pronounced effect on 
selenoprotein expression and the effect occurred in a protein- and tissue- 
specific manner [8]. The most and least affected selenoproteins were 
glutathione peroxidase 1 (GPx 1) and thioredoxin reductase 1 (TR I), 
respectively, and the organs which manifested the most and least affect on 
selenoprotein synthesis were liver and testes, respectively. The mutant Sec 
~ R N A ' ~ ] ~ ~  product from G37trspt lacked the base modification and 
altered the levels of the two host Sec ~ R N A [ ~ ~ ~ ~ ~ ~ ~  isoforms is such a manner
that the Um34 species was reduced and the mcmSu species was enriched. As 
the amount of the mutant tRNA increased with increasing numbers of 
transgenes, the amount of the Um34 species and the amount of some 
selenoproteins, and in particular, GPxl also decreased. The correlation in 
reduction of the Urn34 isoform and certain selenoproteins led us to propose 
that the Um34 modification is responsible for the expression of several 
selenoproteins that are involved in the lower echelon of selenoprotein 
hierarchy expression [5 -71. Interestingly, many of the selenopro teins that are 
expressed in the lower echelon of selenoprotein hierarchy and are sensitive to 
selenium status, such as GPxl , serve largely stress-related functions, while 
those that are expressed in the upper echelon of selenoprotein hierarchy and 
are less sensitive to selenium status, such as TR1, serve largely housekeeping 
functions. Those members associated with stress-related phenomena are the 
ones dependent on the Sec ~RNA[~"]" Um34 modification for their 
expression (see also Chapter 3 and [5-71). 
As shown in Table 1, the ~37trsp '  mice have been used in several different 
studies. The studies have shown that these mice, which are deficient in 
selenoproteins involved in stress-related phenomena, have an enhanced 1) 
skeletal muscle adaptation after synergist ablation and following exercise [9], 
2) incidence of prostate malignancy when the mice also carry an oncogene 
directed to this tissue (see legend to Table I), and 3) incidence of breast 
malignancy when the mice also carry an oncogene directed to this tissue (see 
legend to Table 1). In addition, we have observed that G37trspt mice a 
significantly greater number of azoxymethane (A0M)-induced aberrant crypt 
formations (preneoplastic lesions in the colon) than wild type mice (R Irons, 
BA Carlson, DL Hatfield and CD Davis, submitted). Supplementing the diets 
of the AOM treated G37trspt and wild type mice with 0.1 and 2.0 pglg 
selenium significantly reduced the incidence of preneoplastic lesions in both 
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mouse lines. These observations are the first to provide evidence that both 
selenoproteins and low molecular weight selenocompounds play a role in the 
cancer protective effects of selenium. 
In another study involving Sec ~RNA[*~]" mutant transgenic mice, we 
examined the effect of A34trspt, which also lacked Um34, on selenoprotein 
synthesis (B.A. Carlson, M.E. Moustafa, R. Shrirnali, M. Rao, N. Zhong, S. 
Wang, L. Feigenbaum, B.J. Lee, V.N. Gladyshev and D.L. Hatfield, 
submitted). The effects of A34trspt on down regulating stress-related 
selenoprotein expression were similar to those of ~37trsp'. Since both these 
mutants lack Um34, these observations provided further evidence that Um34 
is responsible governing the expression of those selenoproteins involved in 
stress-related phenomena. 
Transgenic/knockout mouse models 
Since the standard knockout of trsp is embryonic lethal [9,11], it appeared 
that this mutant could not be used for further study of selenoprotein 
expression. However, we devised a means of rescuing selenoprotein 
expression by crossing heterozygous trsp knockout mice with homozygous 
trspt transgenic mice and breeding the offspring to obtain a line of mice 
lacking trsp (Atrsp) that was dependent on the trspt for survival [6,7]. One 
advantage of rescuing a knockout mouse with a wild type or mutant 
transgene is that the number of transgenes, and therefore, the levels of the 
corresponding gene product can be maintained at normal or elevated amounts 
depending on the transgene copy number. Rescuing with 20 copies of the 
wild type transgene enriched the Sec ~ R N A [ ~ ~ ~ ~ ~ ~  population several fold, but 
little or no effect on selenoprotein expression in various tissues or organs 
was observed [6,7]. These observations provided further evidence that Sec 
~ R N A [ * ] ~  is not limiting in selenoprotein biosynthesis (reviewed in [4,5]). 
Rescue of the Atrsp mice with the mutant transgene, ~37trsp'  afforded us 
with an opportunity of obtaining a mouse line with a mutant transgene 
wherein there is no background of host Sec and selenoprotein 
expression is therefore totally dependent on the mutant tRNA. G37trsp 
yielded a tRNA that lacked two base modifications, i6A37 and Urn34 (see 
above, Chapter 3 and [6,10]) and mice rescued with G37trspt lacked several 
selenoproteins including glutathione peroxidases 1 and 3, SelR and SelT 
[6,7]. Interestingly, we were not successful in rescuing selenoprotein 
synthesis in Atrsp mice with A34trspt (see reference to Carlson et a1 above). 
As discussed in greater detail in Chapter 3, the novel regulation of several 
selenoproteins involved in stress-related functions occurs at the level of 
translation. 
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Conditional knockout mouse models 
Removal of trsp from the mouse genome is embryonic lethal [9,11] which 
prevented fwrther study of the standard trsp knockout per se in selenoprotein 
expression. We therefore prepared the conditional knockout of trsp using 
loxP-Cre technology [9]. The removal of floxed trsp in mouse mammary 
epithelium [9] and in liver hepatocytes [12] was examined. trsp was targeted 
for removal in mammary epithelium using transgenic mice carrying the Cre 
recombinase gene under the control of the mouse mammary tumor virus long 
terminal repeat promoter or the whey acidic protein promoter. Neither Cre 
promoter was effective in complete removal of trsp in mammary epithelial 
cells, but the Sec population was substantially reduced to alter 
selenoprotein expression in a protein specific manner [9]. In liver, however, 
the targeted removal of floxed trsp with transgenic mice carrying the Cre 
recombinase under the control of the albumin promoter was virtually 
complete [12]. Surprisingly, the mice survived without selenoprotein 
expression in hepatocytes which comprise about 85% of the liver cell mass. 
Selenoprotein P (SelP), which is the only known selenoprotein with multiple 
Sec residues (see Chapters 9, 10 and 21), would seem to be largely made in 
the liver and transported to other organs and tissues as its level was reduced 
about 75% in plasma of the selenoproteinless liver knockout mice. These 
mice appeared phenotypically normal until about 24 hours before death and 
death appeared to be due to severe hepatocellular degeneration and necrosis 
with concomitant necrosis of peritoneal and retroperitoneal fat [52]. 
Although most animals lacking selenoprotein expression in their liver died 
within two to three months in this initial study, these animals may be kept 
alive for extended periods of time on a diet enriched in other nutrients (U. 
Schweizer, L. Schomburg and J. Kohrle, personal communication). This is 
an important observation since these animals live much longer on a different 
diet and can be subjected to various environmental agents to study the role of 
selenoproteins in liver function and health. 
As selenium has been implicated in heart disease (see Chapter 25) and 
immune function (Chapter 27), we examined the role of selenoproteins in 
cardiovascular disease and the immune system. By targeting the removal of 
trsp in either endothelial cells or myocytes in skeletal and heart muscle, we 
have elucidated the role of selenoproteins in cardiovascular disease (R. 
Shrimali, J.A. Weaver, G.R. Miller, B.A. Carlson, S.V. Novoselov, E. 
Kumaraswamy, V.N. Gladyshev and D.L. Hatfield, submitted). Removal of 
selenoprotein expression in endothelial cells was embryonic lethal. 14.5-day- 
old embryos had numerous abnormalities including necrosis of the central 
nervous system, subcutaneous hemorrhage and erythrocyte immaturity. Loss 
of selenoprotein expression in myocytes, however, manifested no apparent 
phenotype until about day 12 after birth, when affected mice developed 
decreased mobility and an increased respiratory rate, followed by death 
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within a few hours. Although there was no evidence of inflammation of the 
skeletal muscle in mice that lacked trsp in myocytes, they had moderate to 
severe myocarditis with inflammation extending into the mediastinum.. 
Targeted removal of trsp in endothelial cells demonstrated an essential role 
of selenoproteins in their development, while targeted removal of trsp in 
myocytes demonstrated an essential role of selenoproteins in proper function 
of cardiac muscle. These studies also showed a direct connection between the 
loss of selenoprotein expression and cardiovascular disease (R. Shrimali, J.A. 
Weaver, G.R. Miller, B.A. Carlson, S.V. Novoselov, E. Kumaraswamy, V.N. 
Gladyshev and D.L. Hatfield, submitted). 
The conditional knockout of trsp is an important mouse model as it 
provides a means of elucidating the roles of selenoproteins in health, 
development and/or function in tissues or organs for which there is a specific 
promoter. Promoters that function to express Cre early in development of a 
specific tissue or organ can be used to assess the role of selenoproteins in 
development of that tissue or organ. On the other hand, promoters that 
function to express Cre after the tissue or organ is developed can be used to 
assess the role of selenoproteins in proper function of that organ or tissue. 
Furthermore, promoters that function to express Cre either early or late in 
development of a specific tissue or organ, and provided the animal survives 
for a long period of time following trsp knockout, can be used to examine the 
animal's ability to handle various forms of stress (e.g., viral or bacterial 
infection, carcinogen(s), cancer driver gene(s), etc). Those animals that 
survive for long periods of time, while lacking selenoprotein expression in a 
specific tissue or organ, can also be used to assess the role of small molecular 
weight selenocompounds in health. Therefore, the conditional knockout of 
trsp in specific tissues and organs is an important tool for assessing the role 
of selenoproteins in health and development and this model can also be used 
to assess the role of small molecular weight selenocompounds in protecting 
the animal against environmental stresses. 
Transgenic/conditional knockout mouse models 
Although the rescue of mice encoding a Atrsp mice with G37trspt provides a 
novel model for studying the role of housekeeping and stress-related 
selenoproteins in health and the role of the two Sec ~ R N A [ ~ ' ] ~  isoforms in 
governing selenoprotein expression [6,7], this mouse model permit us to 
focus on the animal as a whole and not on not on the roles of these 
components in individual organs and tissues. However, removal of 
selenoprotein expression by targeting floxed trsp with a specific promoter 
Cre and replacing selenoprotein expression with a mutant trspt pemits us to 
assess the role of housekeeping and stress-related selenoproteins, as well as 
the role of both isoforms, in health andlor proper function of specific organs 
or tissues. Selenoprotein removal was targeted in liver of the floxed trsp 
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mouse using the albumin Cre promoter and selenoprotein expression was 
replace with either G37trspt or A34trspt (B.A. Carlson, M.E. Moustafa, R. 
Shrimali, M. Rao, N. Zhong, S. Wang, L. Feigenbaum, B.J. Lee, V.N. 
Gladyshev and D.L. Hatfield, submitted). The pattern of replacing 
selenoprotein expression, wherein several selenoproteins associated with 
stress were not recovered, was similar with either the G37 and A34 mutant 
transgenes. The fact that the two mutant Sec ~ R N A ' ~ ] ~ '  isoforms govern 
selenoprotein expression in virtually an identical manner without the 
influence of host wild type See ~ R N A [ ~ ~ ~ ~ ~  demonstrates that Urn34 is 
responsible for the synthesis of stress-related selenoproteins. 
Importantly, this mouse model will most certainly provide insights into one 
of the central questions in the selenium field which is "What are the 
contribution of selenoproteins versus low molecular weight 
selenocompounds in the cancer chemopreventive effects of selenium and 
other health benefits of this trace element?" Both these mutant transgenes 
replaced housekeeping selenoprotein expression, but not stress-related 
selenoprotein expression. 
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